Innovative Medicines Initiative

Revision as of 13:51, 9 January 2009 by Swilliams (talk | contribs)
Jump to navigation Jump to search
Innovative Medicines Initiative
Joint Technology Initiative on Innovative Medicines
Keywords Drug discovery, Drug development
Funding agency European Commission

European Federation of Pharmaceutical Industries and Associations (EFPIA)

Project type Joint Technology Initiative (JTI)
Reference
Objective Re-invigorate the European bio-pharmaceutical sector and to make Europe more attractive for private research and development (R&D) investment in this sector
Participants
Budget Overall: 2 billion EUR

Funding: 1 billion EUR

Duration 2008 - 2017
Web site http://imi.europa.eu

WikiDoc Resources for Innovative Medicines Initiative

Articles

Most recent articles on Innovative Medicines Initiative

Most cited articles on Innovative Medicines Initiative

Review articles on Innovative Medicines Initiative

Articles on Innovative Medicines Initiative in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Innovative Medicines Initiative

Images of Innovative Medicines Initiative

Photos of Innovative Medicines Initiative

Podcasts & MP3s on Innovative Medicines Initiative

Videos on Innovative Medicines Initiative

Evidence Based Medicine

Cochrane Collaboration on Innovative Medicines Initiative

Bandolier on Innovative Medicines Initiative

TRIP on Innovative Medicines Initiative

Clinical Trials

Ongoing Trials on Innovative Medicines Initiative at Clinical Trials.gov

Trial results on Innovative Medicines Initiative

Clinical Trials on Innovative Medicines Initiative at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Innovative Medicines Initiative

NICE Guidance on Innovative Medicines Initiative

NHS PRODIGY Guidance

FDA on Innovative Medicines Initiative

CDC on Innovative Medicines Initiative

Books

Books on Innovative Medicines Initiative

News

Innovative Medicines Initiative in the news

Be alerted to news on Innovative Medicines Initiative

News trends on Innovative Medicines Initiative

Commentary

Blogs on Innovative Medicines Initiative

Definitions

Definitions of Innovative Medicines Initiative

Patient Resources / Community

Patient resources on Innovative Medicines Initiative

Discussion groups on Innovative Medicines Initiative

Patient Handouts on Innovative Medicines Initiative

Directions to Hospitals Treating Innovative Medicines Initiative

Risk calculators and risk factors for Innovative Medicines Initiative

Healthcare Provider Resources

Symptoms of Innovative Medicines Initiative

Causes & Risk Factors for Innovative Medicines Initiative

Diagnostic studies for Innovative Medicines Initiative

Treatment of Innovative Medicines Initiative

Continuing Medical Education (CME)

CME Programs on Innovative Medicines Initiative

International

Innovative Medicines Initiative en Espanol

Innovative Medicines Initiative en Francais

Business

Innovative Medicines Initiative in the Marketplace

Patents on Innovative Medicines Initiative

Experimental / Informatics

List of terms related to Innovative Medicines Initiative

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The Innovative Medicines Initiative (IMI) is a European initiative to improve the competitive situation of the European Union in the field of pharmaceutical research. The IMI is a joint initiative (Public-Private Partnership) of the DG Research of the European Commission, representing the European Communities, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI is laid out as a Joint Technology Initiative within the Seventh Framework Programme.

The Innovative Medicines Initiative is aimed towards removing research bottlenecks in the current drug development process. The IMI Joint Technology Initiative (IMI JTI), to be implemented by the IMI Joint Undertaking is meant to address these research bottlenecks.

The Sixth Framework Programme's research projects InnoMed AddNeuroMed and InnoMed PredTox act as pilot projects establishing the feasibility of this particular public-private partnership[1].

See also

References

  1. Reference on EFPIA's IMI site [1]

External links

Template:SIB

Template:WH Template:WS